Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVS
NVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVS News
Analysis of Dividend Stocks in the Pharmaceutical Industry
3d ago
Fool
Jim Cramer Updates Bullpen Watchlist with New Stocks
3d ago
CNBC
Anthropic Appoints Novartis CEO to Board
6d ago
seekingalpha
Novartis Expands Heart Disease and Cancer Treatment Programs
Apr 09 2026
seekingalpha
SIDEWINDER THERAPEUTICS SECURES FUNDING WITH SUPPORT FROM FRAZIER LIFE SCIENCES AND NOVARTIS VENTURE FUND
Apr 08 2026
moomoo
Impact of Trump's Tariffs One Year Later
Apr 03 2026
CNBC
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Eli Lilly's AI Investment: Implications for Its Stock Performance.
Mar 30 2026
Barron's
Novartis' Fabhalta Significantly Reduces Kidney Failure Risk
Mar 29 2026
Yahoo Finance
Novartis Proposes Acquisition of Excellergy to Expand Immunology Pipeline
Mar 27 2026
NASDAQ.COM
Novartis Acquires Excellergy to Enhance Immunology Strategy
Mar 27 2026
NASDAQ.COM
Novartis Acquires Excellergy for Up to $2B to Enhance Allergy Portfolio
Mar 27 2026
seekingalpha
Novartis Acquires Excellergy for Up to $2 Billion
Mar 27 2026
Yahoo Finance
Morgan Stanley Increases Novartis AG Target Price to $170, Up from $143
Mar 26 2026
moomoo
ON Holding Leadership Shakeup Amid Growth Slowdown
Mar 25 2026
Fool
Vanguard International High Dividend ETF Investment Advantages
Mar 24 2026
Fool
Show More News
